Escalating concerns over impending tariffs and President Trump's foreign policies have fueled uncertainty and instability in ...
The Japanese Ministry of Health, Labor and Welfare (MHLW) in Japan has approved Sarclisa (isatuximab), in combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback